# Concentration/Meditation Limits Inflammation

> **NCT01835457** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **DRUG:** Lipopolysaccharide
- **BEHAVIORAL:** Concentration/meditation

## Key facts

- **NCT ID:** NCT01835457
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-06
- **Final completion:** 2013-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01835457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01835457, "Concentration/Meditation Limits Inflammation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01835457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*